IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,216 | +10.6% | 600 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $24,618 | +14.8% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $21,444 | -5.4% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $22,662 | -16.1% | 600 | 0.0% | 0.01% | -28.6% |
| Q3 2022 | $27,000 | +22.7% | 600 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $22,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $22,000 | +22.2% | 600 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $18,000 | -10.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $20,000 | -16.7% | 600 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $24,000 | -11.1% | 600 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $27,000 | -20.6% | 600 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $34,000 | +21.4% | 600 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $28,000 | -20.0% | 600 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $35,000 | +25.0% | 600 | 0.0% | 0.01% | +9.1% |
| Q1 2020 | $28,000 | -22.2% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $36,000 | -25.0% | 600 | -25.0% | 0.01% | -31.2% |
| Q3 2019 | $48,000 | -5.9% | 800 | 0.0% | 0.02% | -11.1% |
| Q2 2019 | $51,000 | -21.5% | 800 | 0.0% | 0.02% | -25.0% |
| Q1 2019 | $65,000 | +51.2% | 800 | 0.0% | 0.02% | +41.2% |
| Q4 2018 | $43,000 | – | 800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |